Application of Survival Quilts for prognosis prediction of gastrectomy patients based on the Surveillance, Epidemiology, and End Results database and China National Cancer Center Gastric Cancer database

被引:0
作者
Zhao, Lulu [1 ]
Niu, Penghui [1 ]
Wang, Wanqing [1 ]
Han, Xue [1 ]
Luan, Xiaoyi [1 ]
Huang, Huang [2 ]
Zhang, Yawei [2 ]
Zhao, Dongbing [1 ]
Gao, Jidong [3 ]
Chen, Yingtai [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Dept Pancreat & Gastr Surg,Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Canc Prevent & Control, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Breast Surg Oncol, Shenzhen 518116, Peoples R China
来源
JOURNAL OF THE NATIONAL CANCER CENTER | 2024年 / 4卷 / 02期
关键词
Gastric cancer; Prognosis; Survival Quilts; Overall survival; Cancer specific survival; VALIDATION; RECURRENCE; NOMOGRAM;
D O I
10.1016/j.jncc.2024.01.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Accurate prognosis prediction is critical for individualized-therapy making of gastric cancer patients. We aimed to develop and test 6-month, 1-, 2-, 3-, 5-, and 10-year overall survival (OS) and cancer-specific survival (CSS) prediction models for gastric cancer patients following gastrectomy. Methods We derived and tested Survival Quilts, a machine learning-based model, to develop 6-month, 1-, 2-, 3-, 5-, and 10-year OS and CSS prediction models. Gastrectomy patients in the development set (n = 20,583) and the internal validation set (n = 5,106) were recruited from the Surveillance, Epidemiology, and End Results (SEER) database, while those in the external validation set (n = 6,352) were recruited from the China National Cancer Center Gastric Cancer (NCCGC) database. Furthermore, we selected gastrectomy patients without neoadjuvant therapy as a subgroup to train and test the prognostic models in order to keep the accuracy of tumor-node-metastasis (TNM) stage. Prognostic performances of these OS and CSS models were assessed using the Concordance Index (C-index) and area under the curve (AUC) values. Results The machine learning model had a consistently high accuracy in predicting 6-month, 1-, 2-, 3-, 5-, and 10-year OS in the SEER development set (C-index = 0.861, 0.832, 0.789, 0.766, 0.740, and 0.709; AUC = 0.784, 0.828, 0.840, 0.849, 0.869, and 0.902, respectively), SEER validation set (C-index = 0.782, 0.739, 0.712, 0.698, 0.681, and 0.660; AUC = 0.751, 0.772, 0.767, 0.762, 0.766, and 0.787, respectively), and NCCGC set (C-index = 0.691, 0.756, 0.751, 0.737, 0.722, and 0.701; AUC = 0.769, 0.788, 0.790, 0.790, 0.787, and 0.788, respectively). The model was able to predict 6-month, 1-, 2-, 3-, 5-, and 10-year CSS in the SEER development set (C-index = 0.879, 0.858, 0.820, 0.802, 0.784, and 0.774; AUC = 0.756, 0.827, 0.852, 0.863, 0.874, and 0.884, respectively) and SEER validation set (C-index = 0.790, 0.763, 0.741, 0.729, 0.718, and 0.708; AUC = 0.706, 0.758, 0.767, 0.766, 0.766, and 0.764, respectively). In multivariate analysis, the high-risk group with risk score output by 5-year OS model was proved to be a strong survival predictor both in the SEER development set (hazard ratio [HR] = 14.59, 95% confidence interval [CI]: 1.872-2.774, P < 0.001), SEER validation set (HR = 2.28, 95% CI: 13.089-16.293, P < 0.001), and NCCGC set (HR = 1.98, 95% CI: 1.617-2.437, P < 0.001). We further explored the prognostic value of risk score resulted 5-year CSS model of gastrectomy patients, and found that high-risk group remained as an independent CSS factor in the SEER development set (HR = 12.81, 95% CI: 11.568-14.194, P < 0.001) and SEER validation set (HR = 1.61, 95% CI: 1.338-1.935, P < 0.001). Conclusion Survival Quilts could allow accurate prediction of 6-month, 1-, 2-, 3-, 5-, and 10-year OS and CSS in gastric cancer patients following gastrectomy.
引用
收藏
页码:142 / 152
页数:11
相关论文
共 30 条
  • [1] Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer
    Bando, Etsuro
    Ji, Xinge
    Kattan, Michael W.
    Seo, Ho Seok
    Song, Kyo Young
    Park, Cho-Hyun
    Bencivenga, Maria
    de Manzoni, Giovanni
    Terashima, Masanori
    [J]. CANCER MEDICINE, 2020, 9 (16): : 5708 - 5718
  • [2] The Prognostic Impact of Quitting Smoking at or around Diagnosis on the Survival of Patients with Gastrointestinal Cancers: A Systematic Literature Review
    Caini, Saverio
    Del Riccio, Marco
    Vettori, Virginia
    Raimondi, Sara
    Assedi, Melania
    Vignati, Silvano
    Bonaccorsi, Guglielmo
    Cattaruzza, Maria Sofia
    Bellerba, Federica
    Vagnoni, Giulia
    Duroni, Giacomo
    Gandini, Sara
    [J]. CANCERS, 2022, 14 (16)
  • [3] Prognosis of Young Survivors of Gastric Cancer in China and the US: Determining Long-Term Outcomes Based on Conditional Survival
    Chen, Qi-Yue
    Zhong, Qing
    Wang, Wei
    Chen, Shi
    Li, Ping
    Xie, Jian-Wei
    Wang, Jia-Bing
    Lin, Jian-Xian
    Lu, Jun
    Cao, Long-Long
    Lin, Mi
    Tu, Ru-Hong
    Huang, Ze-Ning
    Lin, Ju-Li
    Zheng, Hua-Long
    Liu, Zhi-Yu
    Zheng, Chao-Hui
    Peng, Jun-Sheng
    Zhou, Zhi-Wei
    Huang, Chang-Ming
    [J]. ONCOLOGIST, 2019, 24 (06) : E260 - E274
  • [4] A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study
    Cui, Yanfen
    Zhang, Jiayi
    Li, Zhenhui
    Wei, Kaikai
    Lei, Ye
    Ren, Jialiang
    Wu, Lei
    Shi, Zhenwei
    Meng, Xiaochun
    Yang, Xiaotang
    Gao, Xin
    [J]. ECLINICALMEDICINE, 2022, 46
  • [5] Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)
    Dos Santos, Melanie
    Lequesne, Justine
    Leconte, Alexandra
    Corbinais, Stephane
    Parzy, Aurelie
    Guilloit, Jean-Marc
    Varatharajah, Sharmini
    Brachet, Pierre-Emmanuel
    Dorbeau, Marine
    Vaur, Dominique
    Weiswald, Louis-Bastien
    Poulain, Laurent
    Le Gallic, Corentin
    Castera-Tellier, Marie
    Galais, Marie-Pierre
    Clarisse, Benedicte
    [J]. BMC CANCER, 2022, 22 (01)
  • [6] Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic review
    Gupta, Vaibhav
    Coburn, Natalie
    Kidane, Biniam
    Hess, Kenneth R.
    Compton, Carolyn
    Ringash, Jolie
    Darling, Gail
    Mahar, Alyson L.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (02) : 847 - 856
  • [7] A grading system for predicting the prognosis of gastric cancer with liver metastasis
    Hori, Soshi
    Honda, Michitaka
    Kobayashi, Hiroshi
    Kawamura, Hidetaka
    Takiguchi, Koichi
    Muto, Atsushi
    Yamazaki, Shigeru
    Teranishi, Yasushi
    Shiraso, Satoru
    Kono, Koji
    Kamiga, Takahiro
    Iwao, Toshiyasu
    Yamashita, Naoyuki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (11) : 1601 - 1607
  • [8] Survival nomogram for different grades of gastric cancer patients based on SEER database and external validation cohort
    Hu, Lei
    Yang, Kang
    Chen, Yue
    Sun, Chenyu
    Wang, Xu
    Zhu, Shaopu
    Yang, Shiyi
    Cao, Guodong
    Xiong, Maoming
    Chen, Bo
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Accurate diagnosis and prognosis prediction of gastric cancer using deep learning on digital pathological images: A retrospective multicentre study
    Huang, Binglu
    Tian, Shan
    Zhan, Na
    Ma, Jingjing
    Huang, Zhiwei
    Zhang, Chukang
    Zhang, Hao
    Ming, Fanhua
    Liao, Fei
    Ji, Mengyao
    Zhang, Jixiang
    Liu, Yinghui
    He, Pengzhan
    Deng, Beiying
    Hu, Jiaming
    Dong, Weiguo
    [J]. EBIOMEDICINE, 2021, 73
  • [10] Jiang YM, 2022, LANCET DIGIT HEALTH, V4, pE340, DOI 10.1016/S2589-7500(22)00040-1